-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Final rule.
SUMMARY:
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for 15 approved new animal drug applications (NADAs) from Cyanamid Agricultural de Puerto Rico, Inc., to Fort Dodge Animal Health.
DATES:
This rule is effective October 10, 2002.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Lonnie W. Luther, Center for Veterinary Medicine (HFV-104), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 301-827-8549, e-mail: lluther@cvm.fda.gov.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
Cyanamid Agricultural de Puerto Rico, Inc., P.O. Start Printed Page 63055Box 243, Manati, PR 00701, has informed FDA that it has transferred ownership of, and all rights and interest in, the following 15 approved NADAs to Fort Dodge Animal Health, A Division of American Cyanamid Co., P.O. Box 1339, Fort Dodge, IA 50501:
NADA Number Trade Name 039-356 RIPERCOL L Bolus; TRAMISOL Cattle Wormer Bolus 039-357 RIPERCOL L Soluble Drench Powder 042-740 RIPERCOL L; TRAMISOL Soluble Drench Powder for Sheep 042-837 RIPERCOL L Wormer Oblets; TRAMISOL Sheep Wormer Oblets 044-015 TRAMISOL Type A Medicated Article 045-455 TRAMISOL Type A Medicated Article 045-513 RIPERCOL L 049-553 RIPERCOL L 092-237 RIPERCOL L-Piperazine Soluble 093-688 RIPERCOL L-Piperazine 101-079 TRAMISOL 10% Pig Wormer; TRAMISOL Hog Wormer 102-437 TRAMISOL Injectable Solution 104-184 STYQUIN 107-085 TRAMISOL 126-237 TRAMISOL Gel Accordingly, the agency is amending the regulations in 21 CFR 520.1242a, 520.1242b, 520.1242c, 520.1242e, 520.1242f, 522.234, 522.1244, and 558.315 to reflect the transfer of ownership and to reflect current format.
Following this change of sponsorship, Cyanamid Agricultural de Puerto Rico, Inc., is no longer the sponsor of any approved application. Accordingly, 21 CFR 510.600(c) is being amended to remove the entries for Cyanamid Agricultural de Puerto Rico, Inc.
This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.
Start List of SubjectsList of Subjects
21 CFR Part 510
- Administrative practice and procedure
- Animal drugs
- Labeling
- Reporting and recordkeeping requirements
21 CFR Parts 520 and 522
- Animal drugs
21 CFR Part 558
- Animal drugs
- Animal feeds
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510, 520, 522, and 558 are amended as follows:
End Amendment Part Start PartPART 510—NEW ANIMAL DRUGS
End Part Start Amendment Part1. The authority citation for 21 CFR part 510 continues to read as follows:
End Amendment Part[Amended]2. Section 510.600 Names, addresses, and drug labeler codes of sponsors of approved applications is amended in the table in paragraph (c)(1) by removing the entry for “Cyanamid Agricultural de Puerto Rico, Inc.” and in the table in paragraph (c)(2) by removing the entry for “043781”.
Start PartPART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS
End Part Start Amendment Part3. The authority citation for 21 CFR part 520 continues to read as follows:
End Amendment Part[Amended]4. Section 520.1242a Levamisole hydrochloride drench and drinking water is amended in paragraph (b)(1) by removing “043781” and by adding in its place “No. 053501”.
[Amended]5. Section 520.1242b Levamisole hydrochloride tablet or oblet (bolus) is amended in paragraph (c) by removing “043781” and by adding in its place “053501”.
[Amended]6. Section 520.1242c Levamisole hydrochloride and piperazine dihydrochloride is amended in paragraph (b) by removing “043781” and by adding in its place “053501”.
[Amended]7. Section 520.1242e Levamisole hydrochloride effervescent tablets is amended in paragraph (b) by removing “043781” and by adding in its place “053501”.
[Amended]8. Section 520.1242f Levamisole hydrochloride gel is amended in paragraph (b) by removing “043781” and by adding in its place “053501”.
Start PartPART 522—IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS
End Part Start Amendment Part9. The authority citation for 21 CFR part 522 continues to read as follows:
End Amendment Part[Amended]10. Section 522.234 Butamisole hydrochloride is amended in paragraph (b) by removing “043781” and by adding in its place “053501”.
[Amended]11. Section 522.1244 Levamisole phosphate injection is amended in paragraph (b) by removing “043781” and by adding in its place “053501”.
Start PartPART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS
End Part Start Amendment Part12. The authority citation for 21 CFR part 558 continues to read as follows:
End Amendment Part[Amended]13. Section 558.315 Levamisole hydrochloride (equivalent) is amended in paragraph (a) by removing “043781” and by adding in its place “No. 053501”.
Start SignatureDated: September 26, 2002.
Andrew J. Beaulieu,
Acting Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.
[FR Doc. 02-25880 Filed 10-9-02; 8:45 am]
BILLING CODE 4160-01-S
Document Information
- Effective Date:
- 10/10/2002
- Published:
- 10/10/2002
- Department:
- Food and Drug Administration
- Entry Type:
- Rule
- Action:
- Final rule.
- Document Number:
- 02-25880
- Dates:
- This rule is effective October 10, 2002.
- Pages:
- 63054-63055 (2 pages)
- PDF File:
- 02-25880.pdf
- CFR: (9)
- 21 CFR 510.600
- 21 CFR 522.234
- 21 CFR 522.1244
- 21 CFR 558.315
- 21 CFR 520.1242a
- More ...